Recent studies have led to the discovery of the molecular lesions in m
otor neurons caused by botulinum neurotoxins. These neurotoxins are me
talloproteinases that enter the cytosol and very specifically cleave p
rotein components of the neuroexocytosis apparatus, Consequently, acet
ylcholine cannot be released and the muscle is paralysed. For this rea
son, botulinum neurotoxins are increasingly being used to treat a vari
ety of conditions where a functional paralysis of neuromuscular juncti
ons is useful as therapy.